This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jose Canseco Speaks On Lance Armstrong's Doping Allegations

HOUSTON, Aug. 31, 2012 /PRNewswire/ -- Jose Canseco expresses his views on the Lance Armstrong doping allegations.

In his second Blog post with the industry popular, Steroid.com, former baseball all-star, Jose Canseco, candidly offers up his empathetic opinion on the potentially title stripping allegations against 7 time Tour de France winner, Lance Armstrong.

Seasoned with his own media scrutiny surrounding steroid use, Canseco admits that his cynicism stems from distrust for the level of influence that politics have on the elite cyclist's current industry battle. The former Oakland A's and Texas Rangers outfielder, and two-time best-selling author of his own tell-all book about steroids in sports, even questions the impact that those same influences have on any title holder accused of using a performance enhancing substance.

"...a lot of times there are opposing forces, the forces that, which are the truth, and the forces which are political forces."

Admitting that actual proof of Armstrong's steroid use has never, and most likely will never be confirmed, the veteran steroid user expresses his belief that Armstrong's hard work and dedication is the true key to his success, and even offers his own sentiment:

"...it's bull----...the hypocrisy in all sports, it's just ridiculous...to me he's the best cyclist in the world...for God's sake he's fought cancer and beat it...give the guy a break, he's incredible..."

Canseco ends his second blog with "Canseco on Steroids" as promised, answering fan questions ranging from the number of professional athletes who were never "caught" using steroids to his future plans with Reality TV. The former ball player reminds fans to contact steroid.com with their questions and signs off with a warning to them claiming to "Get Ready!"

http://www.Steroid.com

This press release was issued through 24-7PressRelease.com.  For further information, visit http://www.24-7pressrelease.com.

SOURCE Steroid.com

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

Chart of I:DJI
DOW 17,550.69 -47.51 -0.27%
S&P 500 2,093.32 -4.72 -0.22%
NASDAQ 5,105.5460 -9.8360 -0.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs